← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Evoq Therapeutics, Inc.
Ann Arbor, MI
$4,844,976
Total funding
4
Grants
Funding over time
peak $2M · FY2022–25$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,844,976 · 4
By mechanism
R44$4,557,243 · 3
R43$287,733 · 1
Investigators at Evoq Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
NanoDiscs for Immune Modulation in Celiac Disease$1,050,000
R44 · FY2025 · AI
Novel immunotherapy against MOG antibody disease$1,000,000
R44 · FY2024 · TR
Novel immunotherapy against MOG antibody disease$988,943
R44 · FY2025 · TR
New approach for immune modulation against T1D$761,809
R44 · FY2023 · DK
New approach for immune modulation against T1D$756,491
R44 · FY2024 · DK
Novel immunotherapy against MOG antibody disease$287,733
R43 · FY2022 · AI